InvestorsHub Logo
Followers 10
Posts 1104
Boards Moderated 0
Alias Born 12/07/2012

Re: None

Thursday, 11/30/2017 2:14:36 PM

Thursday, November 30, 2017 2:14:36 PM

Post# of 38634
“The Par launch of the 5 and 40 mg strengths now provides us with the full line of generic Focalin XR® strengths available in the U.S. market,” said Dr. Isa Odidi, Chief Executive Officer and co-founder of Intellipharmaceutics. “ We expect that making available the full complement of generic Focalin XR® strengths will be seen as a benefit by wholesale purchasers of our product.”

Wonder how much of an affect this will have? Will this possibly boost the rest in of the doses sales? Time will tell I guess.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPCI News